Skip to main content
SpringerLink
Log in

Admission plasma vasopressin levels in children with meningococcal septic shock

  • Neonatal and Pediatric Intensive Care
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective

Vasopressin (AVP) response has been reported to be inappropriately low in adult established septic shock. We studied admission AVP levels in children with meningococcal septic shock (MSS).

Patients and methods

All children with meningococcal infection admitted to our PICU between May 2001 and August 2002 were classified as MSS (persistent hypotension despite fluid therapy, with perfusion abnormalities and the need for vasoactive drug infusion for at least 24 h or until death), or meningococal infection without shock (fever and purpura, with or without meningitis). Blood samples were collected at admission and AVP levels were subsequently determined using Nichols Institute Diagnostics vasopressin assay. Eighteen of 19 children with MSS (7 deaths) and 15 without shock (no death) were included.

Results

In children with MSS median admission AVP level was 41.6 pg/ml (1.4–498.9) and in those without 3.3 pg/ml (1.6–63.8). In children with MSS the AVP level was not correlated with duration of shock and fluid expansion prior to AVP sampling, or with age-adjusted blood pressure and natremia at the time of blood sampling. AVP levels were higher in nonsurvivors, but not significantly so. Only one nonsurvivor had an admission AVP level below 30 pg/ml.

Conclusions

In our children with established MSS who died the admission AVP level Δ were not inappropriately low. Further studies including serial AVP level assessments are needed before concluding that AVP administration is of little interest in children with MSS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. Landry DW, Oliver JA (2001) The pathogenesis of vasodilatory shock. N Engl J Med 345:588–595

    CAS  PubMed  Google Scholar 

  2. Holmes CL, Patel BM, Russell JA, Walley KR (2001) Physiology of vasopressin relevant to management of septic shock. Chest 120:989–1002

    CAS  PubMed  Google Scholar 

  3. Aiura K, Ueda M, Endo M, Kitajima M (1995) Circulating concentrations and physiologic role of atrial natriuretic peptide during endotoxic shock in the rat. Crit Care Med 23:1898–1906

    CAS  PubMed  Google Scholar 

  4. Giusti-Paiva A, De Castro M, Antunes-Rodrigues J, Carnio EC (2002) Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release during experimental septic shock. Crit Care Med 30:1306–1310

    CAS  PubMed  Google Scholar 

  5. Landry DW, Levin HR, Gallant EM, Ashton RC, Seo S, D'Alessandro D, Oz MC, Oliver JA (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95:1122–1125

    CAS  PubMed  Google Scholar 

  6. Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA (2001) Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 29:487–493

    CAS  PubMed  Google Scholar 

  7. Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA (1997) Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25:1279–1282

    CAS  PubMed  Google Scholar 

  8. Malay MB, Ashton RC, Landry DW, Townsend RN (1999) Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 47:699–705

    CAS  PubMed  Google Scholar 

  9. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA (2001) The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 27:1416–1421

    CAS  PubMed  Google Scholar 

  10. Dünser MW, Mayr AJ, Ulmer H, Ritsch N, Knotzer H, Pajk W, Luckner G, Mutz NJ, Hasibeder WR (2001) The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 93:7–13

    PubMed  Google Scholar 

  11. O'Brien A, Clapp L, Singer M (2002) Terlipressin for norepinephrine-resistant septic shock. Lancet 359:1209–1210

    Article  CAS  PubMed  Google Scholar 

  12. Patel BM, Chittock DR, Russell JA, Walley KR (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96:576–582

    CAS  PubMed  Google Scholar 

  13. Ryan DW, Kilner AJ (2002) What about vasopressin? Intensive Care Med 28:810–811

    Google Scholar 

  14. Starc TJ, Rosenzweig EB, Landry DW, Jayakumar A, Smerling AJ, Zucker HA, Trinkaus PM, Biagas KV, Nares MA, Jerome EH, Koumbourlis AC, Schleien CL (2000) Emergency use of vasopressin in children with vasodilatory shock due to sepsis or after bypass. Crit Care Med 28:A71

    Google Scholar 

  15. Rosenzweig EB, Starc TJ, Chen JM, Cullinane S, Timchak DM, Gersony WM, Landry DW, Galantowicz ME (1999) Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation 100 [Suppl II]:II-182–II-186

  16. Choi SJ, Jeffries HE, Willis BL, Newth CJ, Bart RD, Wetzel RC (2003) Vaspressin deficiency in pediatric septic shock. Pediatr Crit Care Med 4:141 (A5)

    Google Scholar 

  17. Martinot A, Leclerc F, Cremer R, Leteurtre S, Fourier C, Hue V (1997) Sepsis in neonates and children: definitions, epidemiology and outcome. Pediatr Emerg Care 13:277–281

    CAS  PubMed  Google Scholar 

  18. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655

    CAS  PubMed  Google Scholar 

  19. Fourrier F, Bricard H, Cohen Y, Daoud P, Guidet B, Huet F, Laterre PF, Marquette CH, Schaller MD, Sollet JP, Tamion F (2000) Corticothérapie au cours du choc septique et du syndrome de détresse respiratoire aiguë. XXème Conférence de consensus en réanimation et médecine d'urgence. Reanim Urgences 9:597–603

    Google Scholar 

  20. Dibley MJ, Staehling N, Nieburg P, Trowbridge FL (1987) Interpretation of z score anthropometric indicators derived from the international growth reference. Am J Clin Nutr 46:749–762

    CAS  PubMed  Google Scholar 

  21. Task Force on blood pressure control in children (1987) Report of the second Task Force on blood pressure control in children. Pediatrics 79:1–25

    PubMed  Google Scholar 

  22. van Doesburg NH, Guimond JG, Mercier JC, Lacroix J, Gauthier M (1994) Surveillance: généralités. In: Lacroix J, Gauthier M, Beaufils F (eds) Urgences et soins intensifs pédiatriques. Les Presses de l'université de Montreal, Doin, Paris, pp 49–78

  23. Pollack MM, Ruttimann UE, Getson PR (1988) Pediatric risk of mortality (PRISM) score. Crit Care Med 16:1110–1116

    CAS  PubMed  Google Scholar 

  24. De Groof F, Joosten KFM, Janssen JAMJL, De Kleijn ED, Hazelzet JA, Hop WCJ, Uitterlinden P, Van Doorn J, Hokken-Koelega ACS (2002) Acute stress response in children with meningococcal sepsis: important differences in the growth hormone /insulin-like growth factor I axis between nonsurvivors and survivors. J Clin Endocrinol Metab 87:3118–3124

    PubMed  Google Scholar 

  25. Van der Kaay DCM, De Kleijn ED, De Rijke YB, Hop WCJ, De Groot R, Hazelzet JA (2002) Procalcitonin as a prognostic marker in meningococcal disease. Intensive Care Med 28:1606–1612

    Article  Google Scholar 

  26. Butt W (2001) Septic shock. Pediatr Clin North Am 48:601–625

    CAS  PubMed  Google Scholar 

  27. Carcillo JA, Fields AI, Task force committee members (2002) Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 30:1365–1378

    PubMed  Google Scholar 

  28. Boykin J De Torrente A, Erickson A, Roberston G, Schriver RW (1978) Role of plasma vasopressin in impaired water excretion of glucocorticoid deficiency. J Clin Invest 62:738–744

    CAS  PubMed  Google Scholar 

  29. Papanek PE, Sladek CD, Raff H (1997) Corticosterone inhibition of osmotically stimulated vasopressin from hypothalamic-neurohypophysial explants. Am J Physiol 272:R158–R162

    CAS  PubMed  Google Scholar 

  30. Liedel J, Meadow W, Nachman J, Koogler T, Kahana MD (2002) Use of vasopressin in refractory hypotension in children with vadilatory shock: five cases and a review of the literature. Pediatr Crit Care Med 3:15–18

    PubMed  Google Scholar 

  31. Scharte M, Meyer J, Van Aken H, Bone HG (2001) Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 29:1756–1760

    CAS  PubMed  Google Scholar 

  32. Kahn JM, Kress JP, Hall JB (2002) Skin necrosis after extravasation of low-dose vasopressin administered for septic shock. Crit Care Med 30:1899–1901

    PubMed  Google Scholar 

  33. Westphal M, Bone HG, Van Aken H, Sielenkämper AW (2002) Terlipressin for haemodynamic support in septic patients: a double-edged sword? Lancet 360:1250–1251

    Google Scholar 

  34. Asfar P (2003) Terlipressin in chronic hyperdynamic endotoxic shock: is it safe? Intensive Care Med 29:154–155

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Réanimation Pédiatrique, Hôpital Jeanne de Flandre, avenue Eugène Aviné, 59037, Lille, France

    F. Leclerc, E. Walter-Nicolet, S. Leteurtre, O. Noizet, A. Sadik, R. Cremer & C. Fourier

Authors
  1. F. Leclerc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Walter-Nicolet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Leteurtre
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. Noizet
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Sadik
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Cremer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. Fourier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Leclerc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leclerc, F., Walter-Nicolet, E., Leteurtre, S. et al. Admission plasma vasopressin levels in children with meningococcal septic shock. Intensive Care Med 29, 1339–1344 (2003). https://doi.org/10.1007/s00134-003-1868-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-003-1868-y

Keywords

Search

Navigation